WebRespiratory. With over 50 years in respiratory care, GSK is committed to helping patients breathe better by continuously redefining treatment for COPD and asthma. We are driven … WebNuvaira, Inc. (formerly Holaira, Inc.), located in Minneapolis, Minnesota is a privately held lung denervation company developing minimally invasive products that aims to make breathing easier for patients suffering from obstructive lung diseases. Funding History. September 2010: $3.0M: May 2011: $5.0M: September 2012: $10.6M: February 2013:
Holaira Hosts Educational Symposium on Targeted Lung
WebApr 3, 2014 · Holaira Inc. has raised $42 million from venture capital funds, paving the way for a European clinical trial of the company's catheter-based system to treat obstructive … WebFeb 11, 2013 · About Holaira - Holaira, Inc. (formerly Innovative Pulmonary Solutions, Inc.) is a privately held lung denervation company developing minimally invasive products to make breathing easier for ... deadliest catch network
Plymouth-based Holaira raises $42 million - Star Tribune
WebMr. Deem joined The Foundry at its inception in 1998. In addition to spearheading the research and invention process on new clinical opportunities, Mr. Deem leads the early stage effort in The Foundry's new companies until the company's CEO and Senior Staff is hired. Prior to joining The Foundry, Mr. Deem served in a founding role as consulting … WebHolaira Inc. Holaira, Inc. designs and manufacturers electromedical equipments. The Company develops devices for the treatment of lung diseases. Holaira serves customers … WebAug 3, 2016 · Founded in 2008, Holaira, Inc., of Minneapolis, Minn., is a privately held company developing the Holaira™ Lung Denervation System to address chronic obstructive pulmonary disease (COPD) by treating the overactive airway nerves during Targeted Lung Denervation (TLD). TLD is a minimally invasive procedure that targets the … deadliest catch new episodes